ESMO 2021—my top three abstracts in breast cancer

por Suppan, Christoph
Publicado 2022

Early stage breast cancer treatment and prognostic factors: Post San Antonio Breast Cancer Symposium 2016

por Suppan, Christoph, Balic, Marija
Publicado 2017

It is time to prepare for D-CARE!

por Suppan, Christoph, Balic, Marija
Publicado 2020

Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype

por Čipak Gašparović, Ana, Milković, Lidija, Dandachi, Nadia, Stanzer, Stefanie, Pezdirc, Iskra, Vrančić, Josip, Šitić, Sanda, Suppan, Christoph, Balic, Marija
Publicado 2019

Tumor Microenvironment in Male Breast Carcinoma with Emphasis on Tumor Infiltrating Lymphocytes and PD-L1 Expression

por Brcic, Iva, Kluba, Andrea Maria, Godschachner, Theresa Marie, Suppan, Christoph, Regitnig, Peter, Dandachi, Nadia, Lax, Sigurd Friedwald, Balić, Marija
Publicado 2023

Neutrophil/Lymphocyte ratio has no predictive or prognostic value in breast cancer patients undergoing preoperative systemic therapy

por Suppan, Christoph, Bjelic-Radisic, Vesna, La Garde, Marlen, Groselj-Strele, Andrea, Eberhard, Katharina, Samonigg, Hellmut, Loibner, Hans, Dandachi, Nadia, Balic, Marija
Publicado 2015

Longitudinal tumor fraction trajectories predict risk of progression in metastatic HR(+) breast cancer patients undergoing CDK4/6 treatment

por Dandachi, Nadia, Posch, Florian, Graf, Ricarda, Suppan, Christoph, Klocker, Eva Valentina, Müller, Hannah Deborah, Lindenmann, Jörg, Terbuch, Angelika, Heitzer, Ellen, Balic, Marija
Publicado 2020

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patients

por Benezeder, Theresa, Tiran, Verena, Treitler, Alexandra A.N., Suppan, Christoph, Rossmann, Christopher, Stoeger, Herbert, Cote, Richard J., Datar, Ram H., Balic, Marija, Dandachi, Nadia
Publicado 2017

Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy

por Müller, Hannah Deborah, Posch, Florian, Suppan, Christoph, Bargfrieder, Ute, Gumpoldsberger, Melanie, Hammer, Robert, Hauser, Hubert, Dandachi, Nadia, Prein, Kurt, Stoeger, Herbert, Lax, Sigurd, Balic, Marija
Publicado 2019

Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment

por Suppan, Christoph, Brcic, Iva, Tiran, Verena, Mueller, Hannah D, Posch, Florian, Auer, Martina, Ercan, Erkan, Ulz, Peter, Cote, Richard J, Datar, Ram H, Dandachi, Nadia, Heitzer, Ellen, Balic, Marija
Publicado 2019

Patterns of Recurrence after Neoadjuvant Therapy in Early Breast Cancer, according to the Residual Cancer Burden Index and Reductions in Neoadjuvant Treatment Intensity

por Suppan, Christoph, Posch, Florian, Mueller, Hannah Deborah, Mischitz, Nina, Steiner, Daniel, Klocker, Eva Valentina, Setaffy, Lisa, Bargfrieder, Ute, Hammer, Robert, Hauser, Hubert, Jost, Philipp J., Dandachi, Nadia, Lax, Sigurd, Balic, Marija
Publicado 2021

Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update

por Rinnerthaler, Gabriel, Singer, Christian, Petru, Edgar, Egle, Daniel, Petzer, Andreas, Pluschnig, Ursula, Gampenrieder, Simon Peter, Pfeiler, Georg, Gnant, Michael, Grünberger, Birgit, Krippl, Peter, Strasser-Weippl, Kathrin, Suppan, Christoph, Brunner, Christine, Pusch, Renate, Sandholzer, Margit, Balic, Marija, Bartsch, Rupert
Publicado 2022